Status:
RECRUITING
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Dry Eye Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 256 patients...
Eligibility Criteria
Inclusion
- Age \>=18 and Age \<=75.
- Clinical diagnosis of dry eye disease.
Exclusion
- History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
- History of phthalmology surgery.
- Pregnant or lactating women.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 20 2024
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04673643
Start Date
July 1 2021
End Date
October 20 2024
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospital
Beijing, China
2
Wu Dong
Beijing, China